Bliss GVS Pharma Limited (BSE: 506197)
Health Care · Pharmaceuticals · IN
Rs582.25
+11.11% today · +266.2% 1Y
Bliss GVS Pharma Limited (BSE: 506197) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $646.54M.
Over the last twelve months the share price has gained 266.2%, trading between 118.35 and 601.30.
Tweenvest scores Bliss GVS Pharma Limited across four factors: quality 77/100, value 19/100, growth 61/100, dividend 68/100. Its strongest factor is quality.
506197 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $646.54M
- Revenue (TTM)
- $106.31M
- P/E
- 46.13
- EPS
- 12.62
- Dividend yield
- 0.34%
- Beta (5Y)
- 1.19
- 52-week high
- Rs601.30
- 52-week low
- Rs118.35
- Avg volume (3M)
- —
- Shares outstanding
- 106.24M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.